<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MCO</journal-id>
<journal-title-group>
<journal-title>Molecular and Clinical Oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9450</issn>
<issn pub-type="epub">2049-9469</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mco.2015.550</article-id>
<article-id pub-id-type="publisher-id">MCO-0-0-550</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Incidence of renal carcinoma in non-functioning kidney due to renal pelvic stone disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>ZENGIN</surname><given-names>KURSAD</given-names></name>
<xref rid="af1-mco-0-0-550" ref-type="aff">1</xref>
<xref ref-type="corresp" rid="c1-mco-0-0-550"/></contrib>
<contrib contrib-type="author"><name><surname>TANIK</surname><given-names>SERHAT</given-names></name>
<xref rid="af1-mco-0-0-550" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>SENER</surname><given-names>NEVZAT CAN</given-names></name>
<xref rid="af2-mco-0-0-550" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>ALBAYRAK</surname><given-names>SEBAHATTIN</given-names></name>
<xref rid="af1-mco-0-0-550" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>EKICI</surname><given-names>MUSA</given-names></name>
<xref rid="af3-mco-0-0-550" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>BOZKURT</surname><given-names>IBRAHIM HALIL</given-names></name>
<xref rid="af4-mco-0-0-550" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>BAKIRTAS</surname><given-names>HASAN</given-names></name>
<xref rid="af1-mco-0-0-550" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>GURDAL</surname><given-names>MESUT</given-names></name>
<xref rid="af1-mco-0-0-550" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>IMAMOGLU</surname><given-names>MUHAMMED ABDURRAHIM</given-names></name>
<xref rid="af1-mco-0-0-550" ref-type="aff">1</xref>
<xref rid="af5-mco-0-0-550" ref-type="aff">5</xref></contrib>
</contrib-group>
<aff id="af1-mco-0-0-550"><label>1</label>Department of Urology, Faculty of Medicine, Bozok University, 66200 Yozgat, Turkey</aff>
<aff id="af2-mco-0-0-550"><label>2</label>Department of Urology, Numune Education and Research Hospital, 01010 Adana, Turkey</aff>
<aff id="af3-mco-0-0-550"><label>3</label>Department of Urology, Faculty of Medicine, Hitit University, 19100 Corum, Turkey</aff>
<aff id="af4-mco-0-0-550"><label>4</label>Department of Urology, Bozyaka Education and Research Hospital, 35140 Izmir, Turkey</aff>
<aff id="af5-mco-0-0-550"><label>5</label>Department of Urology, Diskapi Yildirim Beyazit Education and Research Hospital, 06110 Ankara, Turkey</aff>
<author-notes>
<corresp id="c1-mco-0-0-550"><italic>Correspondence to</italic>: Dr Kursad Zengin, Department of Urology, Faculty of Medicine, Bozok University, 118 Medrese Mahallesi Adnan Menderes Bulvari, 66200 Yozgat, Turkey, E-mail: <email>kursadzengin@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>07</month>
<year>2015</year></pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>04</month>
<year>2015</year></pub-date>
<volume>3</volume>
<issue>4</issue>
<fpage>941</fpage>
<lpage>943</lpage>
<history>
<date date-type="received"><day>04</day><month>02</month><year>2015</year></date>
<date date-type="accepted"><day>15</day><month>04</month><year>2015</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2015, Spandidos Publications</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<abstract>
<p>The objective of This study was to report our pathological findings in nephrectomy specimens from patients treated for non-functioning hydronephrotic kidney due to renal pelvic stone disease. A total of 97 patients who underwent nephrectomy for non-functioning hydronephrotic kidneys between January, 2011 and June, 2014 were retrospectively reviewed. A non-functioning kidney was defined as one having paper-thin parenchyma on urinary ultrasound or computed tomography, exhibiting no contrast visualization in the collecting duct system on intravenous urography and having a split renal function of &#x003C;10&#x0025; on nuclear renal function studies. Following pathological evaluation, 9 patients were diagnosed with xanthogranulomatous pyelonephritis, 9 with malignant tumors and 79 with chronic pyelonephritis. Of the patients with chronic pyelonephritis, 2 also had renal adenomas. The malignant tumors included 3 transitional cell carcinomas (TCC), 2 squamous cell carcinomas (SCC), 3 renal cell carcinomas (RCC) (1 sarcomatoid, 1 papillary and 1 clear cell RCC), whereas 1 patient had concurrent RCC and TCC. In conclusion, non-functioning kidneys, particularly those with kidney stones, should be managed as possible malignancies, due to the higher incidence of malignant tumors in such patients compared with the normal population.</p>
</abstract>
<kwd-group>
<kwd>non-functioning kidney</kwd>
<kwd>renal carcinoma</kwd>
<kwd>renal stone</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Smoking, high consumption of fatty foods, hypertension, diabetes mellitus, obesity and decreased physical activity are considered to be risk factors for renal carcinoma (<xref rid="b1-mco-0-0-550" ref-type="bibr">1</xref>). Chronic inflammation has been proven to promote tumor growth (<xref rid="b2-mco-0-0-550" ref-type="bibr">2</xref>). The effect of chronic irritation on different types of cancer has been previously demonstrated (<xref rid="b3-mco-0-0-550" ref-type="bibr">3</xref>,<xref rid="b4-mco-0-0-550" ref-type="bibr">4</xref>).</p>
<p>Bladder cancer is known to be caused by the chronic inflammation associated with the presence of bladder stones (<xref rid="b5-mco-0-0-550" ref-type="bibr">5</xref>), which results in neoplastic differentiation (<xref rid="b6-mco-0-0-550" ref-type="bibr">6</xref>).</p>
<p>Chronic kidney stone disease may lead to loss of kidney function and subsequent nephrectomy. Chronic kidney stone disease has been shown to be associated with transitional cell carcinoma (TCC) or renal cell carcinoma (RCC) and kidney tumors have been found to be more frequent among patients with kidney stones (<xref rid="b7-mco-0-0-550" ref-type="bibr">7</xref>&#x2013;<xref rid="b9-mco-0-0-550" ref-type="bibr">9</xref>). The number of studies and case reports reporting tumors in specimens from patients undergoing nephrectomy for non-functioning kidney due to kidney stones is limited (<xref rid="b10-mco-0-0-550" ref-type="bibr">10</xref>). Discriminating between benign conditions and malignancies may be difficult in non-functioning kidneys unless nephrectomy is performed, as reported in the literature (<xref rid="b11-mco-0-0-550" ref-type="bibr">11</xref>).</p>
<p>In this study, we aimed to report our pathological findings in nephrectomy specimens from patients treated for non-functioning hydronephrotic kidney due to renal pelvic stones.</p>
</sec>
<sec sec-type="subjects|methods">
<title>Patients and methods</title>
<sec>
<title/>
<sec>
<title>Patients</title>
<p>Between January, 2011 and June, 2014, a total of 97 patients underwent nephrectomy for non-functioning hydronephrotic kidney due to renal pelvic stones at the departments of Urology of Bozok University and Diskapi Education and Research Hospital, Turkey. The pathology reports and patient data were retrospectively reviewed.</p>
<p>This study&#x0027;s protocol was approved by the Local Ethics Committee of Bozok University (604/01-2014).</p>
</sec>
<sec>
<title>Definition of non-functioning kidney</title>
<p>A non-functioning kidney was defined as one having paper-thin parenchyma on urinary ultrasound or computed tomography, exhibiting no contrast visualization in the collecting duct system on intravenous urography and having a split renal function of &#x003C;10&#x0025; on nuclear renal function studies.</p>
</sec>
<sec>
<title>Follow-up</title>
<p>The patient follow-up included urinary ultrasound at 1 and 3 months postoperatively and, if necessary, computed tomography or magnetic resonance imaging.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Patient characteristics</title>
<p>A total of 97 patients underwent nephrectomy for non-functioning hydronephrotic kidney due to renal pelvic stone disease. The mean patient age was 61.98&#x00B1;9.6 years. Of the 97 patients, 40 were female and 57 were male. Of the affected kidneys, 54 were on the right and 43 on the left side.</p>
</sec>
<sec>
<title>Pathological diagnosis</title>
<p>Following pathological evaluation, 9 patients were diagnosed with xanthogranulomatous pyelonephritis, 9 with malignant tumors and 79 with chronic pyelonephritis. Among the patients with chronic pyelonephritis, 2 also had renal adenomas.</p>
<p>The malignant tumors included 3 TCCs, 2 squamous cell carcinomas (SCCs), 3 RCCs (1 sarcomatoid, 1 papillary and 1 clear cell RCC), whereas 1 patient had concurrent RCC and TCC. The pathological diagnosis of the patients is summarized in <xref rid="tI-mco-0-0-550" ref-type="table">Table I</xref>.</p>
</sec>
<sec>
<title>Follow-up</title>
<p>The patients were followed up for a mean of 1.4 years (range, 6 months-3 years). The patients with TCC underwent ureterectomy and bladder cuff excision as an adjuvant operation. One patient required further treatment due to metastatic disease and eventually succumbed to the disease after 11 months. A total of 3 patients required adjuvant chemotherapy and the remaining patients were disease-free at the last follow-up.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In functional kidneys, renal tumors may mimic urolithiasis and renal colic pain; therefore, they may be easier to diagnose. However, this may not be the case for non-functioning kidneys. In functioning kidneys, normal blood flow may be visualized by contrast-imaging studies, unlike non-functioning kidneys (<xref rid="b12-mco-0-0-550" ref-type="bibr">12</xref>). Therefore, tumors in non-functioning kidneys may be harder to diagnose. For the treatment of a non-functioning kidney, simple nephrectomy is usually performed. The estimated age-standardized renal carcinoma incidence per 100,000 individuals is 15.8 for men and 7.1 for women in europe (<xref rid="b13-mco-0-0-550" ref-type="bibr">13</xref>). However, the pathological evaluation revealed an incidence of malignancies of 9.3&#x0025; in our study.</p>
<p>Patients appear to be prone to SCC following years of inflammation in the urinary tract caused by stone disease (<xref rid="b14-mco-0-0-550" ref-type="bibr">14</xref>). There are several reports published on bladder stones and SCC (<xref rid="b15-mco-0-0-550" ref-type="bibr">15</xref>,<xref rid="b16-mco-0-0-550" ref-type="bibr">16</xref>), although SCC associated with kidney stones appears to be less frequent (<xref rid="b17-mco-0-0-550" ref-type="bibr">17</xref>). This may be due to the lack of stasis in the renal pelvis compared to the bladder (<xref rid="b18-mco-0-0-550" ref-type="bibr">18</xref>). Under conditions of stasis, such as in cases with hydronephrotic non-functioning kidneys, the rate of SCC appears to increase. In a study by Shah <italic>et al</italic> (<xref rid="b19-mco-0-0-550" ref-type="bibr">19</xref>), the authors reported 2 cases of untreated/neglected renal stones and suggest the stones to be the cause of malignancy.</p>
<p>Several case reports have been published regarding non-functioning kidneys with kidney stones and SCC. Mathur <italic>et al</italic> (<xref rid="b17-mco-0-0-550" ref-type="bibr">17</xref>) reported a case of renal SCC presenting as a multicystic mass. Verma <italic>et al</italic> (<xref rid="b20-mco-0-0-550" ref-type="bibr">20</xref>) presented a case of SCC and kidney stones and reported the low incidence of this tumor in non-functioning kidneys. In our study, 2 of the 97 patients (2&#x0025;) had SCC in a non-functioning kidney and both cases were associated with kidney stones, similar to the available literature.</p>
<p>In 2007, Yeh <italic>et al</italic> (<xref rid="b12-mco-0-0-550" ref-type="bibr">12</xref>) published their series of 47 patients undergoing nephrectomy for non-functioning kidneys with concurrent stone disease/chronic infection. In that study, &#x007E;51&#x0025; of the patients were diagnosed with malignancy postoperatively, although preoperative imaging studies suggested possible malignancy in only 15&#x0025; of the cases. The tumors included 17 TCCs, 5 RCCs, 1 SCC and 1 epidermoid carcinoma. there were 5 reported deaths during follow-up. In our study population of 97 patients, the pathological examination revealed 9 malignant tumors (9.3&#x0025;), namely 3 TCCs, 2 SCCs, 3 RCCs and 1 case of concurrent RCC and TCC.</p>
<p>The limitations of the present study were its retrospective method and relatively small cohort.</p>
<p>In conclusion, non-functioning kidneys, particularly those with kidney stones, should be managed as a possible malignancies, due to the the higher incidence of malignant tumors in such patients compared with the normal population. Prospective studies designed on larger cohorts are required to confirm these findings.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-mco-0-0-550"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Washio</surname><given-names>M</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Mikami</surname><given-names>K</given-names></name><etal/></person-group><article-title>Cigarette smoking and other risk factors for kidney cancer death in a Japanese population: Japan Collaborative Cohort Study for evaluation of cancer risk (JACC study)</article-title><source>Asian Pac J Cancer Prev</source><volume>14</volume><fpage>6523</fpage><lpage>6528</lpage><year>2014</year><pub-id pub-id-type="doi">10.7314/APJCP.2013.14.11.6523</pub-id><pub-id pub-id-type="pmid">24377561</pub-id></element-citation></ref>
<ref id="b2-mco-0-0-550"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unal</surname><given-names>M</given-names></name><name><surname>Tamer</surname><given-names>L</given-names></name><name><surname>Ate&#x015F;</surname><given-names>NA</given-names></name><name><surname>Akba&#x015F;</surname><given-names>Y</given-names></name><name><surname>Pata</surname><given-names>YS</given-names></name><name><surname>Vayiso&#x011F;lu</surname><given-names>Y</given-names></name><name><surname>Ercan</surname><given-names>B</given-names></name><name><surname>G&#x00F6;r&#x00FC;r</surname><given-names>K</given-names></name><name><surname>Atik</surname><given-names>U</given-names></name></person-group><article-title>Glutathione S-transferase M1, T1 and P1 gene polymorphism in laryngeal squamous cell carcinoma</article-title><source>Am J Otolaryngol</source><volume>25</volume><fpage>318</fpage><lpage>322</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.amjoto.2004.04.003</pub-id><pub-id pub-id-type="pmid">15334395</pub-id></element-citation></ref>
<ref id="b3-mco-0-0-550"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jongthawin</surname><given-names>J</given-names></name><name><surname>Techasen</surname><given-names>A</given-names></name><name><surname>Loilome</surname><given-names>W</given-names></name><name><surname>Yongvanit</surname><given-names>P</given-names></name><name><surname>Namwat</surname><given-names>N</given-names></name></person-group><article-title>Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines</article-title><source>Asian Pac J Cancer Prev</source><volume>13</volume><comment>(Suppl)</comment><fpage>47</fpage><lpage>51</lpage><year>2012</year><pub-id pub-id-type="pmid">23480764</pub-id></element-citation></ref>
<ref id="b4-mco-0-0-550"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>YZ</given-names></name><name><surname>Pan</surname><given-names>L</given-names></name><name><surname>Du</surname><given-names>CJ</given-names></name><name><surname>Ren</surname><given-names>DQ</given-names></name><name><surname>Xie</surname><given-names>XM</given-names></name></person-group><article-title>Association between C-reactive protein and risk of cancer: A meta-analysis of prospective cohort studies</article-title><source>Asian Pac J Cancer Prev</source><volume>14</volume><fpage>243</fpage><lpage>248</lpage><year>2013</year><pub-id pub-id-type="doi">10.7314/APJCP.2013.14.1.243</pub-id><pub-id pub-id-type="pmid">23534731</pub-id></element-citation></ref>
<ref id="b5-mco-0-0-550"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobeissi</surname><given-names>LH</given-names></name><name><surname>Yassine</surname><given-names>IA</given-names></name><name><surname>Jabbour</surname><given-names>ME</given-names></name><name><surname>Moussa</surname><given-names>MA</given-names></name><name><surname>Dhaini</surname><given-names>HR</given-names></name></person-group><article-title>Urinary bladder cancer risk factors: A Lebanese case-control study</article-title><source>Asian Pac J Cancer Prev</source><volume>14</volume><fpage>3205</fpage><lpage>3211</lpage><year>2013</year><pub-id pub-id-type="doi">10.7314/APJCP.2013.14.5.3205</pub-id><pub-id pub-id-type="pmid">23803105</pub-id></element-citation></ref>
<ref id="b6-mco-0-0-550"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>SD</given-names></name><name><surname>Tsai</surname><given-names>MC</given-names></name><name><surname>Lin</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>HC</given-names></name></person-group><article-title>A case-control study on the association between bladder cancer and prior bladder calculus</article-title><source>BMC Cancer</source><volume>13</volume><fpage>117</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1471-2407-13-117</pub-id><pub-id pub-id-type="pmid">23497224</pub-id></element-citation></ref>
<ref id="b7-mco-0-0-550"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saw</surname><given-names>KC</given-names></name><name><surname>Ball</surname><given-names>RY</given-names></name><name><surname>Khan</surname><given-names>NH</given-names></name><name><surname>Pilling</surname><given-names>JR</given-names></name><name><surname>Eardley</surname><given-names>I</given-names></name><name><surname>Ashken</surname><given-names>MH</given-names></name></person-group><article-title>Renal cell carcinoma with osteosarcomatous differentiation simulating staghorn calculus: A case report and literature review</article-title><source>J Urol</source><volume>151</volume><fpage>1607</fpage><lpage>1609</lpage><year>1994</year><pub-id pub-id-type="pmid">8189574</pub-id></element-citation></ref>
<ref id="b8-mco-0-0-550"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arisawa</surname><given-names>C</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Owada</surname><given-names>F</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Kaneko</surname><given-names>K</given-names></name></person-group><article-title>Pelvic kidney associated with staghorn calculus and renal pelvic cancer: A case report</article-title><source>Hinyokika Kiyo</source><volume>41</volume><fpage>209</fpage><lpage>211</lpage><year>1995</year><comment>(In Japanese)</comment><pub-id pub-id-type="pmid">7741074</pub-id></element-citation></ref>
<ref id="b9-mco-0-0-550"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansari</surname><given-names>MS</given-names></name><name><surname>Singh</surname><given-names>I</given-names></name><name><surname>Gupta</surname><given-names>NP</given-names></name></person-group><article-title>Renal stone masquerading as an occult renal cell cancer (incidental RCC)</article-title><source>Int Urol Nephrol</source><volume>36</volume><fpage>235</fpage><lpage>237</lpage><year>2004</year><pub-id pub-id-type="doi">10.1023/B:UROL.0000034684.40774.4b</pub-id><pub-id pub-id-type="pmid">15368702</pub-id></element-citation></ref>
<ref id="b10-mco-0-0-550"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sisodia</surname><given-names>SM</given-names></name><name><surname>Khan</surname><given-names>WAZA</given-names></name><name><surname>Bhavsar</surname><given-names>SP</given-names></name></person-group><article-title>Incidental primary papillary mucinous adenocarcinoma of the renal pelvis in a case of non-functioning kidney due to chronic pyelonephritis and pelvic calculus</article-title><source>Saudi J Kidney Dis Transpl</source><volume>23</volume><fpage>592</fpage><lpage>593</lpage><year>2012</year><pub-id pub-id-type="pmid">22569454</pub-id></element-citation></ref>
<ref id="b11-mco-0-0-550"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalid</surname><given-names>S</given-names></name><name><surname>Zaheer</surname><given-names>S</given-names></name><name><surname>Zaheer</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>I</given-names></name><name><surname>Mohd</surname><given-names>Khalid</given-names></name></person-group><article-title>Xanthogranulomatous pyelonephritis: Rare presentation of a rare disease</article-title><source>South Asian J Cancer</source><volume>2</volume><fpage>4</fpage><year>2013</year><pub-id pub-id-type="doi">10.4103/2278-330X.105863</pub-id><pub-id pub-id-type="pmid">24455529</pub-id></element-citation></ref>
<ref id="b12-mco-0-0-550"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>TH</given-names></name><name><surname>Wu</surname><given-names>HC</given-names></name><name><surname>Chang</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>WC</given-names></name></person-group><article-title>A high association of upper urinary tract transitional cell carcinoma with nonfunctioning kidney caused by stone disease in Taiwan</article-title><source>Urol Int</source><volume>79</volume><fpage>19</fpage><lpage>23</lpage><year>2007</year><pub-id pub-id-type="doi">10.1159/000102907</pub-id><pub-id pub-id-type="pmid">17627162</pub-id></element-citation></ref>
<ref id="b13-mco-0-0-550"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>F</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Galeone</surname><given-names>C</given-names></name><name><surname>Lucchini</surname><given-names>F</given-names></name><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>Boyle</surname><given-names>P</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group><article-title>The changing pattern of kidney cancer incidence and mortality in Europe</article-title><source>BJU Int</source><volume>101</volume><fpage>949</fpage><lpage>958</lpage><year>2008</year><pub-id pub-id-type="doi">10.1111/j.1464-410X.2008.07451.x</pub-id><pub-id pub-id-type="pmid">18241251</pub-id></element-citation></ref>
<ref id="b14-mco-0-0-550"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>Wu J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Qiang</surname><given-names>Xu Z</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Qiang</surname><given-names>Yang S</given-names></name><name><surname>Shun</surname><given-names>Ma H</given-names></name></person-group><article-title>Severe anemia and melena caused by pyeloduodenal fistula due to renal stone-associated squamous cell carcinoma</article-title><source>Pak J Med Sci</source><volume>30</volume><fpage>443</fpage><lpage>445</lpage><year>2014</year><pub-id pub-id-type="pmid">24772159</pub-id></element-citation></ref>
<ref id="b15-mco-0-0-550"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajaian</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>RM</given-names></name><name><surname>Kekre</surname><given-names>NS</given-names></name></person-group><article-title>Squamous cell carcinoma associated with large bladder calculus</article-title><source>ANZ J Surg</source><volume>82</volume><fpage>92</fpage><lpage>93</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1445-2197.2011.05953.x</pub-id><pub-id pub-id-type="pmid">22507514</pub-id></element-citation></ref>
<ref id="b16-mco-0-0-550"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Holley</surname><given-names>JL</given-names></name></person-group><article-title>Squamous cell carcinoma of the bladder in a female associated with multiple bladder stones</article-title><source>BMC Res Notes</source><volume>6</volume><fpage>354</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1756-0500-6-354</pub-id><pub-id pub-id-type="pmid">24007445</pub-id></element-citation></ref>
<ref id="b17-mco-0-0-550"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathur</surname><given-names>S</given-names></name><name><surname>Rana</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Goyal</surname><given-names>V</given-names></name><name><surname>Sangwan</surname><given-names>M</given-names></name></person-group><article-title>Incidentally detected squamous cell carcinoma in non-functioning kidney presenting as multi-cystic mass</article-title><source>J Surg Case Rep</source><volume>2011</volume><fpage>8</fpage><year>2011</year><pub-id pub-id-type="pmid">24950509</pub-id></element-citation></ref>
<ref id="b18-mco-0-0-550"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarrett</surname><given-names>TW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Anderson</surname><given-names>AE</given-names></name><name><surname>Oshinsky</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>AD</given-names></name><name><surname>Weiss</surname><given-names>GH</given-names></name></person-group><article-title>Model of human transitional cell carcinoma: Tumor xenografts in upper urinary tract of nude rat</article-title><source>J Endourol</source><volume>9</volume><fpage>1</fpage><lpage>7</lpage><year>1995</year><pub-id pub-id-type="doi">10.1089/end.1995.9.1</pub-id><pub-id pub-id-type="pmid">7780425</pub-id></element-citation></ref>
<ref id="b19-mco-0-0-550"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>HN</given-names></name><name><surname>Jain</surname><given-names>P</given-names></name><name><surname>Chibber</surname><given-names>PJ</given-names></name></person-group><article-title>Laparoscopic nephrectomy for giant staghorn calculus with non-functioning kidneys: Is associated unsuspected urothelial carcinoma responsible for conversion? Report of 2 cases</article-title><source>BMC Urol</source><volume>6</volume><fpage>1</fpage><year>2006</year><pub-id pub-id-type="doi">10.1186/1471-2490-6-1</pub-id><pub-id pub-id-type="pmid">16398940</pub-id></element-citation></ref>
<ref id="b20-mco-0-0-550"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>N</given-names></name><name><surname>Yadav</surname><given-names>G</given-names></name><name><surname>Dhawan</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>Squamous cell carcinoma of kidney co-existing with renal calculi: A rare tumour</article-title><source>BMJ Case Rep 2011: pii: bcr1020103388</source><year>2011</year></element-citation></ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="tI-mco-0-0-550" position="float">
<label>Table I.</label>
<caption><p>Pathological diagnosis in specimens of nephrectomy for non-functioning kidney due to renal pelvic stones.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Pathological diagnosis</th>
<th align="center" valign="bottom">Patient no.</th>
<th align="center" valign="bottom">Patient age, YRS (mean &#x00B1; SD)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Chronic pyelonephritis</td>
<td align="center" valign="top">79<sup><xref rid="tfn1-mco-0-0-550" ref-type="table-fn">a</xref></sup></td>
<td align="left" valign="top">57.8&#x00B1;8.7</td>
</tr>
<tr>
<td align="left" valign="top">Xanthogranulomatous pyelonephritis</td>
<td align="center" valign="top">9</td>
<td align="left" valign="top">59.2&#x00B1;7.2</td>
</tr>
<tr>
<td align="left" valign="top">Malignant tumors</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;TCC</td>
<td align="center" valign="top">3</td>
<td align="left" valign="top">60.1&#x00B1;10.3</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;RCC</td>
<td align="center" valign="top">3</td>
<td align="left" valign="top">63.4&#x00B1;7.6</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;SCC</td>
<td align="center" valign="top">2</td>
<td align="left" valign="top">64.6&#x00B1;4.5</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;RCC &#x002B; TCC</td>
<td align="center" valign="top">1</td>
<td align="left" valign="top">62</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mco-0-0-550"><label>a</label><p>2 patients also had renal adenomas. SD, standard deviation; TCC, transitional cell carcinoma; RCC, renal cell carcinoma; SCC, squamous cell carcinoma.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
